Desmond Yip

17PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 11, 2026
Predicting adherence of imatinib in gastrointestinal stromal tumor-rise of the machines!

|Feb 19, 2026
Oncological Outcomes after Elective and Emergency Resection of Small Intestinal Neuroendocrine Tumours.

Ibrahim Alibrahim, Denna Fryer, Sameesh Gupta

|Jun 11, 2025
Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Michelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann

|Mar 26, 2025
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial.

Desmond Yip, John Zalcberg, Jean-Yves Blay

|Mar 20, 2025
Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma-Retrospective Review From a Tertiary Care Hospital.

Avtaj Nerwal, Desmond Yip, Sivakumar Gananadha

|Sep 28, 2024
External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer.

Ann-Rong Yan, Desmond Yip, Gregory M Peterson

Pageof 3

Frequent Collaborators

3 joint publications

Jane E Dahlstrom

3 joint publications

Ankit Jain

2 joint publications

Fan Wu

2 joint publications

Sudha Rao